BTC Capital Management Inc. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,819 shares of the healthcare conglomerate’s stock after purchasing an additional 459 shares during the period. BTC Capital Management Inc.’s holdings in UnitedHealth Group were worth $2,934,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in UNH. Harbour Capital Advisors LLC increased its position in UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after purchasing an additional 2,503,090 shares during the last quarter. State Street Corp increased its position in UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after purchasing an additional 1,122,534 shares during the last quarter. Ameriprise Financial Inc. increased its position in UnitedHealth Group by 29.9% during the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock worth $546,574,000 after purchasing an additional 766,573 shares during the last quarter. Swiss National Bank increased its position in shares of UnitedHealth Group by 25.8% during the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after acquiring an additional 763,161 shares during the last quarter. Finally, Karp Capital Management Corp acquired a new stake in shares of UnitedHealth Group during the first quarter valued at about $113,729,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock valued at $14,981,909 in the last ninety days. 0.89% of the stock is owned by corporate insiders.
UNH has been the subject of a number of recent analyst reports. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. Stifel Nicolaus reiterated a “buy” rating and set a $185.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 28th. Cantor Fitzgerald reiterated a “buy” rating and set a $205.00 price target on shares of UnitedHealth Group in a research report on Friday, July 7th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 8th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a research report on Monday, July 10th. Three investment analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $203.59.
UnitedHealth Group Incorporated (UNH) opened at 195.26 on Thursday. The stock has a market cap of $188.79 billion, a P/E ratio of 23.46 and a beta of 0.63. The company has a 50-day moving average of $196.60 and a 200-day moving average of $184.31. UnitedHealth Group Incorporated has a 52 week low of $133.03 and a 52 week high of $200.76.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter last year, the company earned $1.96 earnings per share. UnitedHealth Group’s revenue for the quarter was up 7.7% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.